CEREBRAS SYSTEMS INC (CBRS)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-10-16
$127.21-10.52%
Close 2026-10-16 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-10-16
Research Workspace
Put CBRS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Semiconductors is in supercycle. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisThis stock is volatile — it swings about 4% on a typical day and fell roughly 55% in its worst 12-month stretch.
View RiskCerebras’s data-center capacity and wafer-scale AI systems must support continued revenue growth. Q2 revenue rose 74% year over year, but the quarter missed expectations. The desk provides no current valuation multiple for comparing CBRS with peers. Its price is roughly in line with forecast growth, but the latest miss weakens the case. A 12% next-quarter miss probability is one risk. Its 33% drop from the recent high signals possible thesis repricing. Peer multiples imply a price about 53% above where it trades. Our read remains intact, though this read is provisional.
Trailing returns as of 2026-10-16. CBRS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 12 analysts currently covering CBRS (as of Oct 2026).
Based on 5 Wall Street analysts offering 12-month price targets for CBRS in the last 4 months.
Continue this research
Compare CBRS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CBRS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 1 valuation methods, at three horizons. As of 2026-10-16. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Semiconductors — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put CBRS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Develop and deploy disaggregated inference solutions with partners
Partnership with OpenAI enhances product development prospects.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-16. EPS is implied from price ÷ P/E. Not investment advice.
Current $127.21
The last 12 months of price, then the range of analyst 12-month targets from today’s $127.21.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Stock decline indicates market concerns affecting investment thesis.
Threatens: Expand data center and manufacturing capacity to support growth
Expansion efforts are not yet profitable, raising concerns.
Advances: Expand data center and manufacturing capacity to support growth
Buildout supports growth and aligns with management's objectives.
Advances: Drive core revenue growth with strong year-over-year increases
Significant backlog indicates strong revenue growth potential.
Threatens: Expand data center and manufacturing capacity to support growth
Backlog issues could hinder capacity expansion efforts.
Threatens: Drive core revenue growth with strong year-over-year increases
Core revenue growth is contradicted by falling hardware sales.
Advances: Develop and deploy disaggregated inference solutions with partners
New AI accelerator supports product development objectives.
